Human papillomavirus (HPV) is a significant global health concern, particularly due to its role in the development of cervical cancer and other malignancies. HPV infections are among the most common sexually transmitted infections worldwide, with certain high-risk subtypes responsible for the majority of HPV-related cancers.
Current HPV testing methods rely on lab-based techniques that require specialized equipment, trained personnel, and hours to deliver results. These methods fall short of meeting the demand for rapid, convenient, and accessible testing in clinical settings. To address this, we've developed the VitaSIRO solo™ HPV Assay on VitaSIRO solo™ platform.
VitaSIRO solo™ HPV Assay
REGISTRIERUNGSSTATUS
VitaSIRO solo™ - Molekulare Diagnostik an Ihren Fingerspitzen.
To meet the need for rapid and reliable HPV diagnostics, Credo Diagnostics Biomedical developed the VitaSIRO solo™ HPV Assay, a Point-of-Care Testing (POCT) solution that detects and differentiates high-risk HPV subtypes. Using three fluorescence channels, the assay identifies HPV16, HPV18/45, and 11 other high-risk subtypes with accuracy.
Designed for use with cervical swabs, the assay provides results in 45 minutes with a “sample in, result out” process. This fast diagnostic tool enables healthcare providers to quickly guide patient care, improving the management of HPV-related risks in time-sensitive situations.
Benutzerfreundlichkeit
- Minimale Schulung erforderlich
- Keine zusätzliche Ausrüstung erforderlich
- Lagerung bei Raumtemperatur
Leistung
- Quick & Rapid Results
- Inclusivity
- Intuitive Auswertung der Ergebnisse anhand des Ct-Werts und der Fluoreszenzkurve
Diagnostisches Verfahren in 3 Schritten

Sammeln Sie
Probe sammeln

Übertragung
Übertragen Sie die Probe
in die Kartusche.

Startlauf
Results reported in
45 minutes

Sammeln Sie
Probe sammeln

Übertragung
Übertragen Sie die Probe
in die Kartusche.

Startlauf
Results reported in
45 minutes
Intuitive Ergebnisinterpretation
VitaSIRO solo™ HPV Assay
Catalog No.
PCRAD1104
Technology
Nucleic Acid Extraction + Real-Time PCR
Quantity
12 test/box
Turnaround Time
45 minutes
Targets
• HPV 16
• HPV 18/45
• HPV 31, 33, 35, 39, 51, 52, 56, 58, 59, 66, 68
• Sample Adequacy Control (SC)
Specimen
Cervical swabs (including ectocervical and endocervical) in PreservCyt® Solution
Hands-on Time
< 1 minute
Kit Storage
4~30°C